Structural modification of siRNA for efficient gene silencingSO JIN LEE; SEJIN SON; JI YOUNG YHEE et al.Biotechnology advances. 2013, Vol 31, Num 5, pp 491-503, issn 0734-9750, 13 p.Article

Kit and PDGFR-α activities are necessary for Notch4/Int3-induced tumorigenesisRAAFAT, A; ZOLTAN-JONES, A; STRIZZI, L et al.Oncogene (Basingstoke). 2007, Vol 26, Num 5, pp 662-672, issn 0950-9232, 11 p.Article

Enrichment strategies for siRNA-transfected cells in an untransfected backgroundNARZ, Frank; HÜBNER, Silke; MAGYAR, Silvia et al.Journal of biotechnology. 2007, Vol 130, Num 3, pp 209-212, issn 0168-1656, 4 p.Article

Picking a winner: new mechanistic insights into the design of effective siRNAsDELQUIN GONG; FERRELL, James E.Trends in biotechnology (Regular ed.). 2004, Vol 22, Num 9, pp 451-454, issn 0167-7799, 4 p.Article

Unlocking the money-making potential of RNAiHOWARD, Ken.Nature biotechnology. 2003, Vol 21, Num 12, pp 1441-1446, issn 1087-0156, 6 p.Article

Therapeutic potential of siRNA-mediated transcriptional gene silencingMORRIS, Kevin V.BioTechniques. 2006, Num avril, pp 7-13, issn 0736-6205, 7 p., SUPArticle

Rational siRNA design for RNA interferenceREYNOLDS, Angela; LEAKE, Devin; BOESE, Queta et al.Nature biotechnology. 2004, Vol 22, Num 3, pp 326-330, issn 1087-0156, 5 p.Article

Expression profiling reveals off-target gene regulation by RNAiJACKSON, Aimee L; BARTZ, Steven R; SCHELTER, Janell et al.Nature biotechnology. 2003, Vol 21, Num 6, pp 635-637, issn 1087-0156, 3 p.Article

RNA interference as a novel and powerful tool in immunopharmacological researchYAN KONG; LINGFEI RUAN; LILI MA et al.International immunopharmacology. 2007, Vol 7, Num 4, pp 417-426, issn 1567-5769, 10 p.Article

Allele-specific RNA interference for neurological diseaseRODRIGUEZ-LEBRON, E; PAULSON, H. L.Gene therapy (Basingstoke). 2006, Vol 13, Num 6, pp 576-581, issn 0969-7128, 6 p.Article

Involvement of tiam1 in apoptosis induced by bufalin in HeLa cellsCAO-HONG; SHIBAYAMA-IMAZU, Toshiko; MASUDA, Yutaka et al.Anticancer research. 2007, Vol 27, Num 1A, pp 245-249, issn 0250-7005, 5 p.Article

RNAi therapeutics : Principles, prospects and challengesAAGAARD, Lars; ROSSI, John J.Advanced drug delivery reviews. 2007, Vol 59, Num 2-3, pp 75-86, issn 0169-409X, 12 p.Article

Development of siRNA for therapeutics : Efficient synthesis of phosphorothioate RNA utilizing phenylacetyl disulfide (PADS)RAVIKUMAR, Vasulinga T; ANDRADE, Mark; CARTY, Recaldo L et al.Bioorganic & medicinal chemistry letters (Print). 2006, Vol 16, Num 9, pp 2513-2517, issn 0960-894X, 5 p.Article

Antagonism of transforming growth factor-β signaling inhibits fibrosis-related genesLIU, Xing-Jun; RUAN, Cheng-Mai; GONG, Xian-Feng et al.Biotechnology letters. 2005, Vol 27, Num 20, pp 1609-1615, issn 0141-5492, 7 p.Article

RNA interference silencing the transcriptional message: Aspects and applicationsKARKARE, Shantanu; DANIEL, Saurabha; BHATNAGAR, Deepak et al.Applied biochemistry and biotechnology. 2004, Vol 119, Num 1, pp 1-12, issn 0273-2289, 12 p.Article

In vivo gene silencing in solid tumors by targeted electrically mediated siRNA deliveryGOLZIO, M; MAZZOLINI, L; COUDERC, B et al.Gene therapy (Basingstoke). 2007, Vol 14, Num 9, pp 752-759, issn 0969-7128, 8 p.Article

PEI-alginate nanocomposites as efficient in vitro gene transfection agentsPATNAIK, Soma; AGGARWAL, Anita; NIMESH, Surendra et al.Journal of controlled release. 2006, Vol 114, Num 3, pp 398-409, issn 0168-3659, 12 p.Article

Development and characterisation of chitosan nanoparticles for siRNA deliveryKATAS, Haliza; OYA ALPAR, H.Journal of controlled release. 2006, Vol 115, Num 2, pp 216-225, issn 0168-3659, 10 p.Article

Gene therapy progress and prospects : non-viral gene therapy by systemic deliveryLI, S.-D; HUANG, L.Gene therapy (Basingstoke). 2006, Vol 13, Num 18, pp 1313-1319, issn 0969-7128, 7 p.Article

DICER-LIKE 4 is required for RNA interference and produces the 21-nucleotide small interfering RNA component of the plant cell-to-cell silencing signalDUNOYER, Patrice; HIMBER, Christophe; VOINNET, Olivier et al.Nature genetics. 2005, Vol 37, Num 12, pp 1356-1360, issn 1061-4036, 5 p.Article

Using siRNA technique to generate transgenic animals with spatiotemporal and conditional gene knockdownCHANG, Hung-Shu; LIN, Ching-Hui; CHEN, Yu-Chi et al.The American journal of pathology. 2004, Vol 165, Num 5, pp 1535-1541, issn 0002-9440, 7 p.Article

Quorum-sensing-based toolbox for regulatable transgene and sirna expression in mammalian cells : Cell Culture Engineering IXWEBER, Wilfried; MALPHETTES, Laetitia; RINDERKNECHT, Matthias et al.Biotechnology progress. 2005, Vol 21, Num 1, pp 178-185, issn 8756-7938, 8 p.Article

Inhibition of HIV-1 protease expression in T cells owing to DNA aptamer-mediated specific delivery of siRNAQINCHANG ZHU; SHIBATA, Takayuki; KABASHIMA, Tsutomu et al.European journal of medicinal chemistry. 2012, Vol 56, pp 396-399, issn 0223-5234, 4 p.Article

Therapeutic RNA interference of malignant melanoma by electrotransfer of small interfering RNA targeting MitfNAKAI, N; KISHIDA, T; SHIN-YA, M et al.Gene therapy (Basingstoke). 2007, Vol 14, Num 4, pp 357-365, issn 0969-7128, 9 p.Article

RNA interference in miceKUHN, R; STREIF, S; WURST, W et al.Handbook of experimental pharmacology. 2007, Vol 178, pp 149-176, issn 0171-2004, 28 p.Article